Choice of Frontline Tyrosine‐Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A “Campus <scp>CML</scp>” Study

2024-9-12

A Real‐World Data‐Based Analysis of Prognostic Indices as Part of Trial Eligibility Criteria in Diffuse Large B‐Cell Lymphoma Patients

2024-9-10

Venetoclax Combined With <scp>FLAG</scp>‐<scp>IDA</scp> in Refractory or Relapsed Acute Myeloid Leukemia

2024-9-9

A New Strategy for Adult T‐Cell Leukemia Treatment Targeting Glycogen Synthase Kinase‐3β

2024-9-6

Perinatal Outcomes Following Intravenous Iron for Treatment of Iron Deficiency With and Without Anemia

2024-9-3

Issue Information

2024-9-3

Idiopathic multicentric Castleman disease with marrow fibrosis and extramedullary hematopoiesis

2024-8-29

Safety and efficacy of <scp>B cell maturation antigen</scp>‐directed <scp>CAR T</scp>‐cell therapy in patients with relapsed/refractory multiple myeloma and concurrent light chain amyloidosis

2024-8-27

<scp><i>MYC</i></scp> translocation is a valuable marker for the development and relapse of extramedullary disease in multiple myeloma

2024-8-27

Efficacy of ixazomib, lenalidomide, dexamethasone regimen in daratumumab‐exposed relapsed/refractory multiple myeloma patients: A retrospective analysis

2024-8-26

The cardiotoxic effects of CAR‐T cell therapy: An updated systematic review and meta‐analysis

2024-8-22

Plasma monomeric ApoA1 and high‐density lipoprotein bound ApoA1 are markedly decreased and associated with low levels of lipophilic antioxidants in sickle cell disease: A potential new pathway for therapy

2024-8-20

Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation

2024-8-18

Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide based prophylaxis

2024-8-14

Graft‐versus‐host disease in patients with bone marrow transplants: A retrospective study analyzing outcomes and healthcare burden in <scp>US</scp> hospitals

2024-8-12

Venetoclax‐based non‐intensive induction followed by allogenic stem‐cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics

2024-8-11

Mortality risk associated with weekend and holiday hospitalizations amongst patients with hematological malignancies and febrile neutropenia

2024-8-8

Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1‐mutated AML

2024-8-8

Recurrent venous thromboembolism and vaginal estradiol in women with prior venous thromboembolism: A nested case–control study

2024-8-8

Myelofibrosis and anemia: A German claims data analysis to describe epidemiology and current treatment

2024-8-5

Issue Information

2024-8-2

Health‐related quality of life in older hematological cancer survivors (70+) compared to older general population—A German cancer‐register‐based cross‐sectional comparative study

2024-8-1

Retroperitoneal and lower extremities muscle bleeding in acquired haemophilia A (<scp>AHA</scp>): Risk factors and implications in disability and survival

2024-7-31

Comparison of R‐<scp>CHOP</scp>‐14 and R‐mini‐<scp>CHOP</scp> in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study

2024-7-31

Antiemetic prophylaxis regimens in haematologic malignancies patients undergoing a hematopoietic stem cell transplantation. Which is the best standard of care? A systematic review

2024-7-29

Treatment and clinical outcomes of patients with acute myeloid leukemia in Finland 2010–2020: A retrospective analysis of electronic health records

2024-7-29

Posttransplantation cyclophosphamide mediates effective reconstitution of memory B cells after allogeneic hematopoietic cell transplantation

2024-7-28

Effectiveness of R‐<scp>CHOP</scp> versus R‐<scp>CHOEP</scp> for treatment of young patients with high‐risk diffuse large B‐cell lymphoma: A Danish observational population‐based study

2024-7-22

A systematic review of the literature on localized gastrointestinal tract amyloidosis: Presentation, management and outcomes

2024-7-19

Disease and treatment burden of patients with haemophilia entering the explorer6 non‐interventional study

2024-7-19

Real‐world effectiveness of first‐line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy

2024-7-18

Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with <i>BCR</i>::<i>ABL1</i> digital <scp>PCR</scp> in chronic myeloid leukemia patients

2024-7-12

An open‐label, first‐in‐human, single agent, dose escalation study for the evaluation of safety and efficacy of <scp>SAR442085</scp> in patients with relapsed or refractory multiple myeloma

2024-7-12

The impact of hematology electronic consultations on the management of iron deficiency

2024-7-12

Use of allopurinol to manage skewed 6‐mercaptopurine metabolism in pediatric maintenance acute lymphoblastic leukemia treatment

2024-7-11

<scp>CRP</scp> and <scp>sCD25</scp> help distinguish between adult‐onset Still's disease and <scp>HLH</scp>

2024-7-10

Characteristics of large granular lymphocyte leukemia associated with variable common immunodeficiency disorders: A study of 12 cases

2024-7-10

Outcomes with low dose anti‐thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantation

2024-7-9

Aberrant early hematopoietic progenitor formation marks the onset of hematopoietic defects in Shwachman–Diamond syndrome

2024-7-5

Novel biomarkers to identify complicated course of febrile neutropenia in hematological patients receiving intensive chemotherapy

2024-7-3

A single‐day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies

2024-7-2

Risk factors of death or chronic renal replacement therapy requirements in patients with thrombotic microangiopathies without <scp>ADAMTS‐13</scp> deficiency

2024-7-2

Issue Information

2024-7-2

The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease <scp>HbS</scp>/β‐thalassaemia and no or low <scp>HbA</scp> expression

2024-6-30

Marked hyperferritinemia in critically ill cancer patients

2024-6-27

Prophylaxis with recombinant factor IX Fc fusion protein reduces the risk of bleeding and delays time to first spontaneous bleed event in previously untreated patients with haemophilia B: A post hoc analysis of the PUPs B‐LONG study

2024-6-25